(Q36310912)

13 August 2017

1 reference

title

Diabetic nephropathy and anaemia (English)

1 reference

13 August 2017

1 reference

Ritz E

1

1 reference

13 August 2017

Haxsen V

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

European Journal of Clinical Investigation

13 August 2017

published in

1 reference

13 August 2017

volume

35 Suppl 3

1 reference

13 August 2017

page(s)

66-74

1 reference

Nephropathy in patients with type 2 diabetes mellitus

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Uremic patients--late referral, early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

PAX6 mutation as a genetic factor common to aniridia and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

How should we manage anaemia in patients with diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Diabetic Nephropathy in Type 2 Diabetes Prevention and Patient Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

The anemia of primary autonomic failure and its reversal with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Nitric oxide's reactions with hemoglobin: a view through the SNO-storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Anemia management and the delay of chronic renal failure progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Treatment of anemia in the diabetic patient with retinopathy and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Cardiovascular complications in the diabetic patient with renal disease: an update in 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Cardiac disease in diabetic end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Physiological role of CLC-K1 chloride channel in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Cardiovascular consequences of renal anaemia and erythropoietin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

Targeted delivery of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01544.X

10.1111/J.1365-2362.2005.01544.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference